Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology

Retrieved on: 2021-08-18 12:33:45

Tags for this article:

Click the tags to see associated articles and topics

Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology. View article details on hiswai:

Excerpt

(NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. ...

Article found on: finance.yahoo.com